UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange For the Quarterly Period Ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction of incorpo ...

Anthem, Inc. (ANTM) Q4 2020 Earnings Conference Call January 27, 2021 8:30 AM ET Company Participants Chris Rigg – Vice President-Investor Relations Gail Boudreaux – President and Chief Executive Officer John Gallina – Chief Financial Officer Pete Haytaian – President-Commercial and Specialty Business Division Felicia Norwood – President-Government Business Division Conference Call Participants Justin Lake – Wolfe Research A.J. Rice – Credit Suisse Steven Valiquette – Barclays Ricky Goldwasser – Morgan Stan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange For the Quarterly Period Ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission f ...

Financial Data and Key Metrics Changes - Anthem reported Q3 2020 GAAP earnings per share of $0.87 and adjusted earnings per share of $4.20, down 14% year-over-year [8][35] - Operating revenue for Q3 2020 was $30.6 billion, an increase of approximately 16% compared to the prior year quarter [43] - The medical loss ratio in Q3 was 86.8%, a decrease of 40 basis points year-over-year [44] Business Line Data and Key Metrics Changes - Medical membership totaled 42.6 million members, an increase of 172,000 members sequentially, driven by growth in Medicaid and Medicare [25][40] - Medicaid membership grew by nearly 390,000 lives in the quarter, up nearly 18% year-to-date [28] - The Medicare business grew more than 16% year-to-date, outperforming the market average [31] Market Data and Key Metrics Changes - Commercial membership declined 0.9% sequentially, but new account sales outpaced lapses for the second consecutive quarter [26] - The Large Group segment saw net new risk sales exceed lapses in 11 of the last 13 months [27] - Non-COVID utilization returned to normal levels, approximately 95% of historical baseline [45] Company Strategy and Development Direction - Anthem is focused on improving the health of humanity and addressing health disparities through community health initiatives [10][11] - The company is investing in AI and digital capabilities to enhance customer experience and streamline operations [60][62] - Anthem aims to achieve an SG&A ratio of 11% to 12% by 2023, reallocating resources to high-growth areas [37][38] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in membership trends, outperforming internal expectations despite economic challenges [26] - The company anticipates headwinds from Medicaid reverifications and commercial enrollment pressures in 2021 [56] - Anthem maintains its 2020 adjusted earnings guidance of greater than $22.30, reflecting strong performance amid uncertainty [51] Other Important Information - Anthem's third quarter operating gain was $201 million, a decline of $1.3 billion from the prior year [39] - The company repurchased 2.9 million shares at a total cost of $759 million in the quarter [50] - Anthem was named to Forbes Annual List Of The Most Just Companies, ranking number one in the healthcare sector for the second consecutive year [17] Q&A Session Summary Question: Clarification on higher investment spending - Management indicated that higher investment spending is focused on AI and digital capabilities to improve member engagement and care access [59][60] Question: 2021 outlook growth rate base - The 2021 outlook growth rate is based on 2020 guidance, with adjustments for pandemic-related risks [66] Question: Medicaid rate actions for 2021 - Management expects to achieve appropriate returns on capital and operate within target margin ranges in Medicaid for 2021 [77] Question: Utilization trends and procedures returning - Management noted that outpatient surgeries have recovered faster than pre-COVID levels, while ER utilization remains below baseline [82][84] Question: Medicaid enrollment and reverification timing - States are expected to suspend reverifications through the public health emergency, with timing for resuming evaluations left to state discretion [90][102] Question: Impact of Blue Cross Blue Shield settlement - The settlement will not change the long-term growth strategy, and the company has fully accrued its estimated liability [106]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n ...

Anthem, Inc. (ANTM) Q2 2020 Earnings Conference Call July 29, 2020 8:30 AM ET Company Participants Chris Rigg - Vice President, Investor Relations Gail Boudreaux - President and Chief Executive Officer John Gallina - Chief Financial Officer Felicia Norwood - President of Government Business Division Pete Haytaian - President of Commercial and Specialty Business Division Conference Call Participants Ricky Goldwasser - Morgan Stanley Justin Lake - Wolf Research Stephen Tanal - SVB Leerink A.J. Rice - Credit ...

Anthem, Inc. (ANTM) Q1 2020 Earnings Conference Call April 29, 2020 8:30 AM ET Company Participants Chris Rigg - Vice President, Investor Relations Gail Boudreaux - President & Chief Executive Officer John Gallina - Chief Financial Officer Pete Haytaian - President of Commercial & Specialty Business Division Felicia Norwood - President of Government Business Division Conference Call Participants Ralph Giacobbe - Citi Justin Lake - Wolf Research A.J. Rice - Credit Suisse Stephen Valiquette - Barclays Gary T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ANTM New York Stock Exchange ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ANTHEM, INC. (Exact name of registrant as specified in its charter) Indiana 35-2145715 (State or other jurisdiction of incorpo ...